您当前的位置:
首页 >
文章列表页 >
Current status and progress of nucleic acid point-of-care testing technology based on CRISPR/Cas system
Precise targeting—tumor | 更新时间:2025-10-21
    • Current status and progress of nucleic acid point-of-care testing technology based on CRISPR/Cas system

    • Journal of Chongqing Medical University   Vol. 47, Issue 8, Pages: 910-916(2022)
    • 作者机构:

      陆军军医大学第一附属医院检验科,重庆 400038

    • DOI:10.13406/j.cnki.cyxb.003087.    

      CLC: R446.19
    • Received:18 June 2022,

      Published:28 August 2022

    移动端阅览

  • Feng Liu,Chang Kai,Chen Ming.Current status and progress of nucleic acid point-of-care testing technology based on CRISPR/Cas system[J].Journal of Chongqing Medical University,2022,47(8):910-916. DOI: 10.13406/j.cnki.cyxb.003087..

  •  
  •  

0

Views

3

下载量

1

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Research advances in the clinical application of lateral flow assay-based point-of-care testing
Establishment and application of the method for detecting DHBV DNA in serum using DHBV DNA probe labeled directly by alkaline phosphatase
Retrospective analysis of 2019 novel coronavirus nucleic acid test results among individuals of different age and gender in Hubei Province

Related Author

Meng Ruyan
Ji Jianing
Zhao Yan
Zhang Yufang
Wang Xing
Wang Zhizeng
CHEN Yaxi
et al

Related Institution

Center for Smart Inspection and Molecular Medicine,School of Medicine,Chongqing University
National and Local Joint Engineering Laboratory for Antibody Drug Development,Henan University
Department of Nuclear Medicine,The Affiliated Hospital of Southwest Medical University
Institute of Viral Hepatitis,Chongqing Medical University
重庆医科大学病毒性肝炎研究所
0